Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.21 - $2.4 $931 - $1,848
-770 Reduced 2.99%
24,999 $30,000
Q1 2024

May 15, 2024

BUY
$1.76 - $3.45 $45,353 - $88,903
25,769 New
25,769 $60,000
Q2 2023

Aug 14, 2023

BUY
$2.13 - $7.13 $54,832 - $183,547
25,743 Added 118.8%
47,413 $115,000
Q1 2023

May 15, 2023

SELL
$5.52 - $9.23 $121,859 - $203,761
-22,076 Reduced 50.46%
21,670 $124,000
Q4 2022

Feb 14, 2023

BUY
$7.72 - $21.27 $337,719 - $930,477
43,746 New
43,746 $391,000
Q2 2022

Aug 15, 2022

BUY
$10.26 - $20.81 $171,957 - $348,775
16,760 New
16,760 $245,000
Q1 2022

May 16, 2022

SELL
$11.53 - $19.97 $157,845 - $273,389
-13,690 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.37 - $17.49 $100,895 - $239,438
13,690 New
13,690 $239,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $39.6M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.